Research advances in oral mucositis

Current Opinion in Oncology

Volumn 11, Issue 4, 1999, Pages 261-266

  Peterson, Douglas E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER SURVIVAL; CANCER THERAPY; HEALTH CARE COST; HUMAN; INFECTION RISK; MOUTH MUCOSA; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MOUTH MUCOSA; RESEARCH; STOMATITIS;

EID: 0033000116     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199907000-00005     Document Type: Review

References (31)

1. 1 NIH Consensus Development Conference on oral complications of cancer therapies: diagnosis, prevention and treatment. NCI Monogr 9:1990.
2. 2 Squier CA: Mucosal alterations. NCI Monogr 1990, 9:169-172.
3. 3 Sonis ST: Mucositis as a biological process a new hypothesis for the development of chemotherapy-induced stomatoxicity. Oral Oncol 1998, 34:39-43. A concise presentation of the current model for mucositis based on literature to date.
4. 4 Wilkes JD: Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol 1998, 25:538-551. Excellent contemporary review of the clinical issues relative to oral mucositis. Pathophysiology and a summary of clinical research relative to prevention and treatment are addressed.
5. 5 Peterson DE: Effect of misoprostol in reducing oral mucositis in stem cell transplant patients [abstract]. Proceedings of the 11th Multinational Association of Supportive Care in Cancer 1999, 67.
6. 6 Symonds RP: Treatment-induced mucositis: an old problem with new remedies. Br J Cancer 1998, 77:1689-1695.
7. 7 Meta-Analysis Group in Cancer: Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol 1998, 16:3537-3541.
8. 8 Lucas VS, Roberts GJ, Beighton D: Oral health of children undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 22:801-808.
9. 9 Larson PJ, Miaskowski C, MacPhail L, Dodd MJ, Greenspan D, Dibble SL, et al.: The PRO-SELF Mouth Aware program: an effective approach for reducing chemotherapy-induced mucositis. Cancer Nurs 1998, 21:263-268.
10. 10 Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al.: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798-1804.
11. 11 Wardley AM, Booth D, Roberts SA, Scarffe JH, Potten CS: A quantitative histometric murine in vivo model of radiation-induced oral mucositis. Arch Oral Biol 1998, 43:567-577.
12. 12 Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, et al.: Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998, 58:933-939. An important murine study involving keratinocyte growth factor efficacy. This model could have value in other studies examining mucosal cytokine alterations in relation to mucositis.
13. 13 Anderson PM, Schroeder G, Skubitz KM: Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998, 83:1433-1439.
14. 14 Oblon DJ, Paul SR, Oblon MB, Malik S: Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation. Bone Marrow Transplant 1997, 20:961-963.
15. 15 Karthaus M, Rosenthal C, Huebner G, Paul H, Elser C, Hertenstein B, et al.: Effect of topical oral G-CSF on oral mucositis: a randomized placebo-controlled trial. Bone Marrow Transplant 1998, 22:781-785.
16. 16 Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, Kyprianou K, Kolitsi G, Dardoufas K: A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report. Int J Radiat Oncol Biol Phys 1998, 42:551-556.
17. 17 Johnston EM, Crawford J: Hematopoietic growth factors in the reduction of chemotherapeutic toxicity. Semin Oncol 1998, 25:552-561.
18. 18 Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH, Mulagha MT, et al. for the Mucositis Study Group: Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999, 85:2103-2113.
19. 19 Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK: Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Cancer 1992, 69:2469-2477.
20. 20 McGuire DM, Peterson DE, Muller S, Owen DC, Slemmons M: The 20 item Oral Mucositis Index: reliability and validity in bone marrow and stem cell transplant patients [abstract]. Proceedings of the 11th Multinational Association of Supportive Care in Cancer 1999, 148.
21. 21 Stokman MA, Spijkervet FKL, Wijmenga ANM, de Vries EGE, Burlage F, Timens W: Quantification of irradiation mucositis by an assay determining the viability of epithelial cells [abstract]. Proceedings of the 11th Multinational Association of Supportive Care in Cancer 1999, 148.
22. 22 Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST: The impact of mucositis on α-hemolytic streptococci infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998, 82:2275-2281.
23. 23 Orlicek SL, Branum KC, English BK, McCordic R, Shenep JL, Patrick CC: Viridans streptococcal isolates from patients with septic shock induce tumor necrosis factor-α production by murine macrophages. J Lab Clin Med 1997, 130:515-519.
24. 24 Yuen K, Woo PCY, Liang RHS, Chiu EKW, Chen FFE, Wong SSY, et al.: Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbial Infect Dis 1998, 30:75-81.
25. 25 Ferra C, de Sanjose S, Lastra CF, Marti F, Marin̄o EL, Sureda A, et al.: Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplant 1997, 20:1075-1080.
26. 26 Oguchi M, Shikama N, Sasaki S, Gomi K, Katsuyama Y, Ohta S, et al.: Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. Int J Radiat Oncol Biol Phys 1998, 40:1033-1037.
27. 27 Feld R: Are surveillance cultures useful in patients likely to develop chemotherapy-induced mucositis? Topics Supp Care Cancer 1998,.
28. 28 Pillitteri LC, Clark RE: Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998, 22:495-498.
29. 29 Zucker TP, Flesche CW, Germing U, Schrǒter S, Willers R, Wolf HH, Heyll A: Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain 1998, 75:305-312.
30. 30 Yamamura K, Ohta S, Yano K, Yotsuyanagi T, Okamura T, Nebeshima T: Oral mucosal adhesive film containing local anesthetics: in vitro and clinical evaluation. J Biomed Mater Res 1998, 43:313-317.
31. 31 Schubert MM, Peterson DE, Lloid ME: Oral complications. In Hematopoietic Cell Transplantation, edn 2. Edited by Thomas ED, Blume KG, Forman SJ, Malden, MA: Blackwell Science, Inc; 1999:751-763.